• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Scroll to next section Scroll to next section

Non-Sponsored Content


MEDICAL NEWS ASIA

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

By: Stijn van den Borne, MSc | Last updated: 26 April 2019 | In: Therapeutic Areas, Hernia Repair, Medical News Asia, News, Surgery

Article Keywords

inguinal disruption, NovusScientific, surgical matrix, surgical mesh, TIGR

UPPSALA, Sweden, April 24, 2019 /PRNewswire/ — Researchers of the Erasmus University Medical Center in Rotterdam − the Netherlands, consider that the synthetic and fully resorbable TIGR® Matrix surgical mesh (Novus Scientific AB, Uppsala − Sweden) may reduce frequent risks related to the surgical repair of Sportsman’s hernia.

Inguinal disruption – also commonly referred to as Sportman’s hernia – is a group name for painful injuries in the groin area caused by repetitive strain and strenuous training. It occurs in up to 28% of high-performing athletes, and may occasionally affect non-athletes.1Sheen AJ, et al. Br J Sports Med. 2014;48(14):1079-87.,2Nam A & Brody F. J Am Coll Surg. 2008;206(1):154-64.

Unlike true hernias, a Sportsman’s hernia does not include the bulging of organs or fatty tissue through a hole in the weakened muscle or tendons of the abdomen.1Sheen AJ, et al. Br J Sports Med. 2014;48(14):1079-87.

The initial treatment of Sportman’s hernia includes physical therapy, rehabilitation programs, sometimes in combination with steroid injections.1Sheen AJ, et al. Br J Sports Med. 2014;48(14):1079-87.

“A treatment option for patients not responding to initial therapy is placement of a permanent mesh by minimally invasive procedure,” explained Prof. Johan Lange of the Department of Surgery at the Erasmus University MC. “Such mesh aims to support the damaged tendons and absorbs pressure during physical exercise.”

Despite the promising results and often fast resumption of sport activities by the patient after the surgical repair, there have been several reports of chronic pain and other severe side effects related to permanent mesh placement.3Doctor HG. J Minim Access Surg. 2006;2(3):110-6.

According to Prof. Gert-Jan Kleinrensink of the Department of Neuroscience at the Erasmus University MC, permanent, non-absorbable meshes can cause serious complications, including chronic post-operative pain. “We are very interested to evaluate whether a slowly resorbable surgical mesh, such as the TIGR® Matrix, could help prevent these issues.”

The researchers of the R.E.P.A.I.R study group, who have published around 200 peer-reviewed articles on the use of surgical meshes in various procedures, are now planning a study to investigate the usefulness of the TIGR® Matrix surgical mesh for the treatment of inguinal disruption.

About the TIGR®Matrix

TIGR®Matrix is the first long-term resorbable, 100% synthetic, surgical mesh. Its unique technology consisting of dual-stage degradation and full resorption, paired with ease of use, is a significant step forward in surgical mesh technology.

The fast-degrading part improves the mesh’ flexibility and stretchability, provides extra strength during the immediate healing phase, and gradually absorbs during the first four months. The slow-degrading part of the mesh provides optimal strength for up to nine months with complete resorption in approximately three years. TIGR®Matrix uses 100% synthetic polymers that are well documented, clinically proven, and commonly used in medical devices since the 1970s.

About Novus Scientific

Novus Scientific AB (www.novusscientific.com) develops, manufactures and markets resorbable implants that help the body’s own healing. The headquarter, research and production facilities are located in Uppsala, Sweden.

Source

1. Sheen AJ, et al. Br J Sports Med. 2014;48(14):1079-87.
2. Nam A & Brody F. J Am Coll Surg. 2008;206(1):154-64.
3. Doctor HG. J Minim Access Surg. 2006;2(3):110-6.


YOU MAY ALSO LIKE

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

https://medi-paper.com/wp-content/uploads/2022/11/At-the-Heart-of-the-Discussion.-COVID-19-Cardiovascular-Complications-in-the-Pregnant-Women.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-11-06 07:53:422022-11-07 08:56:16At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Personalised Angina Treatment at Cellular Level

Personalised Angina Treatment at Cellular Level

https://medi-paper.com/wp-content/uploads/2022/08/Personalised-Angina-Treatment-at-Cellular-Level.png 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-11 02:19:232022-08-11 07:51:24Personalised Angina Treatment at Cellular Level
Previous Previous Previous Next Next Next
At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women
6 November 2022

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks
26 August 2022

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2019 MediPaper Medical Communications Ltd. – Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail

YOU MAY ALSO LIKE

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

https://medi-paper.com/wp-content/uploads/2022/11/At-the-Heart-of-the-Discussion.-COVID-19-Cardiovascular-Complications-in-the-Pregnant-Women.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-11-06 07:53:422022-11-07 08:56:16At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Personalised Angina Treatment at Cellular Level

Personalised Angina Treatment at Cellular Level

https://medi-paper.com/wp-content/uploads/2022/08/Personalised-Angina-Treatment-at-Cellular-Level.png 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-11 02:19:232022-08-11 07:51:24Personalised Angina Treatment at Cellular Level
Dosing issues with DOACs in Asian real world setting

Dosing issues with DOACs in Asian real world setting

https://medi-paper.com/wp-content/uploads/2021/12/Dosing-issues-with-DOACs-in-Asian-real-world-setting-e1645234196630.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-23 18:58:462022-02-20 04:03:16Dosing issues with DOACs in Asian real world setting
The-evolution-of-hypertension-management

The evolution of hypertension management

https://medi-paper.com/wp-content/uploads/2021/08/The-evolution-of-hypertension-management.jpg 1024 1917 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-08-20 16:34:052022-02-20 10:31:52The evolution of hypertension management
COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases

COVID-19 impacting regular patient care for cardiovascular diseases

https://medi-paper.com/wp-content/uploads/2021/02/COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-17 11:52:282022-05-17 05:46:03COVID-19 impacting regular patient care for cardiovascular diseases
SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy

SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy

https://medi-paper.com/wp-content/uploads/2021/02/SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-10 15:41:562022-05-17 05:46:03SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy
Registry data shows early and large LDL reductions are associated with lowest post-MI cardiovascular event rates

Registry data shows early and large LDL reductions are associated with lowest post-MI cardiovascular event rates

https://medi-paper.com/wp-content/uploads/2021/02/Registry-data-shows-early-and-large-LDL-reductions-are-associated-with-lowest-post-MI-cardiovascular-event-rates.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-10 10:35:042022-02-20 03:45:02Registry data shows early and large LDL reductions are associated with lowest post-MI cardiovascular event rates
data-for-safe-and-effective-use-of-evolocumab-in-paediatric-familial-hypercholesterolaemia

Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia

https://medi-paper.com/wp-content/uploads/2020/10/data-for-safe-and-effective-use-of-evolocumab-in-paediatric-familial-hypercholesterolaemia.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-10-08 16:12:402022-05-17 05:46:04Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia
psoriasis-biologics-may-help-reduce-coronary-plaque

Psoriasis biologics may help reduce coronary plaque

https://medi-paper.com/wp-content/uploads/2020/10/psoriasis-biologics-may-help-reduce-coronary-plaque.webp 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-10-08 15:45:112022-05-17 05:46:04Psoriasis biologics may help reduce coronary plaque
ticagrelor-may-not-confer-post-mi-benefits-to-elderly-patients

Ticagrelor may not confer post-MI benefits to elderly patients

https://medi-paper.com/wp-content/uploads/2020/10/ticagrelor-may-not-confer-post-mi-benefits-to-elderly-patients.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-10-08 15:05:532022-05-17 05:46:04Ticagrelor may not confer post-MI benefits to elderly patients
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272022-05-17 05:46:04Evidence of SARS-CoV2 in heart cells
risk-of-thrombosis-with-sars-cov-2-infection

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072022-05-17 05:46:04Risk of thrombosis with SARS-CoV-2 infection
further-analyses-of-dapa-hf-shows-dapagliflozin-leads-to-fewer-outpatient-heart-failure

Class effect of SGLT2 inhibitors on heart failure reduction solidified with dapagliflozin and empagliflozin results

https://medi-paper.com/wp-content/uploads/2020/08/further-analyses-of-dapa-hf-shows-dapagliflozin-leads-to-fewer-outpatient-heart-failure.jpg 1024 1818 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 14:40:232022-02-24 03:54:01Class effect of SGLT2 inhibitors on heart failure reduction solidified with dapagliflozin and empagliflozin results
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132022-02-24 03:59:44Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Highlights of the 8th Asia Pacific Symposium on Cerebrovascular Disease

https://medi-paper.com/wp-content/uploads/2019/12/Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2019-12-16 10:35:082022-02-24 09:16:12Highlights of the 8th Asia Pacific Symposium on Cerebrovascular Disease
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Transcatheter aortic valve replacement reduces severe aortic stenosis in real-world study

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-09-28 15:23:462018-09-28 15:23:46Transcatheter aortic valve replacement reduces severe aortic stenosis in real-world study
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Transcatheter- vs surgical aortic valve replacement in high-risk patients: 5-years survival

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-09-28 12:43:062018-09-28 12:43:06Transcatheter- vs surgical aortic valve replacement in high-risk patients: 5-years survival
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Anti-coagulation: impact on long-term mortality and early valve dysfunction

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-09-19 10:30:462018-09-19 10:30:46Anti-coagulation: impact on long-term mortality and early valve dysfunction
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-08-29 23:13:062018-08-29 23:13:06Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Febuxostat prevents CV events in hyperuricaemia patients

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-08-29 11:32:012018-08-29 11:32:01Febuxostat prevents CV events in hyperuricaemia patients
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

Standard- and low-dose rivaroxaban in Asians with AF: Effectiveness and Safety

0 0 scienterrific https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png scienterrific2018-07-30 09:51:512018-07-30 09:51:51Standard- and low-dose rivaroxaban in Asians with AF: Effectiveness and Safety
Somazina-citicoline-small-vessel-disease-vascular-cognitive-impairment-traumatic-brain-injury-neuroimaging-cerebrovascular-disorders-ischaemic-haemorraghic-stroke-rehabilitation-neuroprotection

ASCO16 Nivolumab (Opdivo©) Data

0 0 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2016-05-29 00:44:422016-05-29 00:44:42ASCO16 Nivolumab (Opdivo©) Data
Previous Previous Previous Next Next Next
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© Copyright 2019 MediPaper Medical Communications Ltd. – Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Link to: Pembrolizumab plus axitinib FDA approved for the first-line treatment of advanced renal cell carcinoma patients Link to: Pembrolizumab plus axitinib FDA approved for the first-line treatment of advanced renal cell carcinoma patients Pembrolizumab plus axitinib FDA approved for the first-line treatment of advanced... Link to: Ivosidenib FDA-approved as first-line treatment for AML patients with IDH1 mutation Link to: Ivosidenib FDA-approved as first-line treatment for AML patients with IDH1 mutation Ivosidenib FDA-approved as first-line treatment for AML patients with IDH1 ...
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only